Abstract
Recognition of an impaired immune system has implications for the diagnosis, treatment and outcome of infections. Not only the type of immunological dysfunction but also the degree of the dysfunction is important. A review is presented of the systemic diseases and immunosuppressive agents which may result in defects in host defence and associated infections. Especially in transplant patients and patients with HIV infection, knowledge of the stage of the host defence defect is important for the success of prophylactic regimens and for the clinical approach in the event of infection.
Similar content being viewed by others
References
Gransden WR, Eykyn SJ, Philips I, Rowe B: Bacteremia due toEscherichia coli: a study of 861 episodes. Reviews of Infectious Diseases 1990, 12: 1008–1018.
van der Meer JWM: Defects in host-defense mechanisms. In: Rubin RH, Young LS (ed): Clinical approach to infection in the compromised patient. Plenum, New York, 1988, p. 41–73.
Allen JC: The diabetic as a compromised host. In: Allen JC (ed): Infection and the compromised host. Clinical correlates and therapeutic approaches. Williams & Wilkins. Baltimore, 1981, p. 229–270.
Hostetter MK: Effects of hyperglycemia on C3 andCandida albicans. Diabetes 1990, 39: 271–275.
Esmann V.: The polymorphonuclear leukocyte in diabetes mellitus. Journal of Clinical Chemistry and Clinical Biochemistry 1983, 21: 561–567.
Hostetter MK, Lorenz JS, Preus L, Kendrick KE: The iCrb receptor onCandida albicans: subcellular localization and modulation of receptor expression by glucose. Journal of Infections Diseases 1990, 161: 761–768.
Artis WM, Fountain JA, Delcher HK, Jones HE: A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982, 31: 1109–1114.
Daly AL, Velasquez LA, Bradley SF, Kauffman CA: Mucormycosis: association with deferoxamine therapy. American Journal of Medicine 1989, 87: 468–471.
Rubin J, Yu VL: Malignant external otitis: insights into pathogenesis, clinical manifestations diagnosis and therapy: American Journal of Medicine 1988, 85: 391–398.
Goldblum SE, Reed WP: Host defenses and immunologic alterations associated with chronic hemodialysis. Annals of Internal Medicine 1980, 74: 481–493.
Ruiz P, Gomez F, Schreiber AD: Impaired function of macrophage Fcy receptors in end-stage renal disease. New England Journal of Medicine 1990, 322: 717–722.
Frank MM, Lawley TJ, Hamburger MI Brown EJ: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Annals of Internal Medicine 1983, 98: 206–218.
Schreiber AD, Nettl FM, Sanders MC, King M, Szabolcs P, Friedman D, Gomez F: Effect of endogenous and synthetic sex steroids on the clearance of antibody-coated cells. Journal of Immunology 1988, 141: 2959–2966.
Jones WG, Minei JP, Richardson RP Fahey TJ, Calvano SE, Antonacci AC, Shires GT: Pathophysiologic glucocorticosteroid elevations promote bacterial translocation after thermal injury. Infection and Immunity 1990, 58: 3257–3261.
Gordon DL, Rice JL, Avery VM: Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 191–197.
Kim JH, Langston AA, Gallis HA: Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Reviews of Infectious Diseases 1990, 12: 583–590.
MacGregor RR: Alcohol and immune defense. Journal of American Medical Association 1986, 256: 1474–1479.
Wilcox CM, Dismukes WE: Spontaneous bacterial peritonitis. A review of pathogenesis, diagnosis and treatment. Medicine 1987, 66: 447–456.
Runyon BA: Patients with deficient ascites fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988, 8: 632–635.
Gines P, Rimola A, Planas R, Vargas V, Marco F, Almela M, Forne M, Miranda ML, Llach J, Salmeron JM, Esteve M, Marques JM, Jimenez de Anata MT, Arrova V, Rodes J: Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind placebo-controlled trial. Hepatology 1990, 12: 716–724.
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP: Risk factors for hospital-acquired candidemia. A matched case-control study. Archives of Internal Medicine 1989, 149: 2349–2353.
Cupps TR, Fauci AS: Corticosteroid-mediated immunoregulation in man. Immunological Reviews 1982, 65: 133–155.
Kim JH, Perfect JR: Infection and cyclosporine. Reviews of Infectious Diseases 1989, 11: 677–690.
Stuck AE, Minder CE, Frey FJ: Risk of infectious complications in patients taking glucocorticosteroids. Reviews of Infectious Diseases 1989, 11: 954–963.
Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH: Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. Journal of Infectious Diseases 1983, 148: 230–238.
Gorensek MJ, Stewart RW, Keys TF, Mehta AC, McHenry MC, Goormastic M: A multivariate analysis of risk factors for pneumonia following cardiac transplantation. Transplantation 1988, 46: 860–865.
Dale DC, Fauci AS, Wolff SM: Alternate-day prednisone: leukocyte kinetics and susceptibility to infections. New England Journal of Medicine 1974, 291: 1154–1158.
Rubin RH, Tolkoff-Rubin NE: Opportunistic infections in renal allograft recipients. Transplantation Proceedings 1988, 6, Supplement 8: 12–18.
Paya CV, Hermans PE, Washington A, Smith TF, Anhalt JP, Wiesner RH, Krom RAF: Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantation. Mayo Clinics Proceedings 1989, 64: 555–564.
Gentry LO, Zeluff B: Infection in the cardiac transplant patient. In: Rubin RH, Young LS (ed): Clinical approach to infection in the compromised patient. Plenum, New York, 1988, p. 623–648.
Wreghitt TG, Hakim M, Gray JJ, Balfour AH, Stovin PGI, Stewart S, Scott J, English TAH, Wallwork J: Toxoplasmosis in heart and heart and lung transplant recipients. Journal of Clinical Pathology 1989, 42: 194–199.
van der Meer JWM, Guiot HFL, van den Broek PJ, van Furth R: Infections in bone marrow transplant recipients. Seminars in Hematology 1984, 21: 123–140.
Meyers JD: Infections in bone-marrow transplant recipients. American Journal of Medicine 1986, 81, Supplement 1A: 27–38.
Horsburgh CR:Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. New England Journal of Medicine 1991, 324: 1332–1338.
Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA: Pulmonary aspergillosis in the acquired immunodeficiency syndrome. New England Journal of Medicine 1991, 324: 654–662.
Armstrong D: Problems in the management of opportunistic fungal diseases. Reviews of Infectious Diseases 1989, 11, Supplement 7: 1591–1599.
Schlamm HT, Yancovitz SR:Haemophilus influenzae pneumonia in young adults with AIDS, ARC, or risk of AIDS. American Journal of Medicine 1989, 86: 11–14.
Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Cinant M: B-cell immunodeficiency in acquired immune deficiency syndrome. Journal of American Medical Association 1984, 251: 1447–1449.
Bender BS, Frank MM, Lawley TJ, Smith WJ, Brickman CM, Quinn TC: Defective reticuloendothelial system Fc-receptor function in patients with the acquired immunodeficiency syndrome. Journal of Infectious Diseases 1985, 152: 409–412.
Corazza CR, Zoli G, Ginaldi L, Cancellieri C, Profeta V, Gasbarrini G, Quaglino D: Tuftsin deficiency in AIDS. Lancet 1991, 337: 12–13.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Marie, S. Diseases and drug-related interventions affecting host defence. Eur. J. Clin. Microbiol. Infect. Dis. 12 (Suppl 1), S36–S41 (1993). https://doi.org/10.1007/BF02389876
Issue Date:
DOI: https://doi.org/10.1007/BF02389876